Premium
COSMIC, c hemotherapy plus o fatumumab at s tandard or m ega‐dose i n c hronic lymphocytic leukaemia, a phase II randomised study
Author(s) -
Allsup David,
Howard Dena,
Emmerson Jake,
Hockaday Anna,
Rawstron Andy,
Oughton Jamie B.,
Bloor Adrian,
Phillips David,
Nathwani Amit,
Paneesha Shankara,
Turner Deborah,
Munir Talha,
Hillmen Peter
Publication year - 2021
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.17526
Subject(s) - ofatumumab , medicine , chemoimmunotherapy , obinutuzumab , fludarabine , rituximab , oncology , chemotherapy , cyclophosphamide , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom